Inventiva SA Schedule 13G passive stakes
Filed when an investor crosses five percent without intending to seek control — the passive counterpart to a 13D.
NASDAQ
IVA
Inventiva SADeep Track Capital, LP, along with its affiliates, has reported beneficial ownership of 7,800,465 ordinary shares, representing 3.76% of Inventiva S.A.'s outstanding shares as of March 31, 2026.
NASDAQ
IVA
Inventiva SAEventide Asset Management and associated individuals have reduced their beneficial ownership in Inventiva S.A. to 4.6% as of December 31, 2025.
NASDAQ
IVA
Inventiva SADeep Track Capital and affiliates have reported a 6.07% beneficial ownership stake in Inventiva S.A., including ordinary shares, ADSs, and warrants.
NASDAQ
IVA
Inventiva SAPerceptive Advisors and its affiliates have reported a 4.99% beneficial ownership stake in Inventiva S.A., including ordinary shares and various warrants.
NASDAQ
IVA
Inventiva SAGreat Point Partners, along with Dr. Jeffrey R. Jay and Ms. Lillian Nordahl, reported a 6.06% beneficial ownership stake in Inventiva S.A. through a Schedule 13G filing.
NASDAQ
IVA
Inventiva SAYiheng Capital Partners, L.P. and its affiliates have disclosed a 5.46% beneficial ownership stake in Inventiva S.A. ordinary shares.
NASDAQ
IVA
Inventiva SAAndera Partners and related entities have reported a beneficial ownership of 8.8% in Inventiva S.A. ordinary shares.
NASDAQ
IVA
Inventiva SAInvus Public Equities, along with affiliated entities and Raymond Debbane, has reported a 10.6% beneficial ownership stake in Inventiva S.A., totaling 14,814,813 ordinary shares.
NASDAQ
IVA
Inventiva SAGreat Point Partners, LLC, along with Dr. Jeffrey R. Jay and Ms. Lillian Nordahl, have jointly disclosed a beneficial ownership of 7.42% in Inventiva S.A., totaling 10,576,827 ordinary shares.
NASDAQ
IVA
Inventiva SAEventide Asset Management, LLC, along with Finny Kuruvilla and Robin C. John, has disclosed a beneficial ownership of 6.7% of Inventiva S.A.'s Ordinary Shares.
NASDAQ
IVA
Inventiva SAAndera Partners, BioDiscovery 6 FPCI, and their managing partners have jointly disclosed a beneficial ownership of 6.5% of Inventiva S.A.'s ordinary shares.
NASDAQ
IVA
Inventiva SAInvus Public Equities, L.P. and its affiliated entities have reported a 7.8% beneficial ownership stake in Inventiva S.A., held for passive investment purposes.
NASDAQ
IVA
Inventiva SASCHEDULE 13G: Perceptive Advisors Discloses 5.8% Stake in Inventiva S.A. Through Schedule 13G Filing
Perceptive Advisors LLC, along with Joseph Edelman and Perceptive Life Sciences Master Fund, Ltd., has disclosed a 5.8% beneficial ownership stake in Inventiva S.A., totaling 5,555,555 ordinary shares.
NASDAQ
IVA
Inventiva SASCHEDULE 13G/A: Sofinnova Entities Affirm 7.2% Beneficial Stake in Inventiva S.A. Through Amended SEC Filing
Sofinnova Crossover I SLP and its related entities have filed an amended Schedule 13G, reaffirming their beneficial ownership of 7.2% of Inventiva S.A.'s voting rights as of December 31, 2024.
NASDAQ
IVA
Inventiva SASCHEDULE 13G/A: Pierre Broqua Discloses Significant Stake in Inventiva S.A. with Enhanced Voting Rights
Pierre Broqua has filed an amended Schedule 13G, disclosing a 4.3% beneficial ownership stake in Inventiva S.A., which translates to 7.4% of the total voting power due to double voting rights on a portion of his holdings.